These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 12920658

  • 1. Influence of postmenopausal hormone replacement therapy on an estrogen metabolite biomarker of risk for breast cancer.
    Alvarez-Vasquez RB, Axelrod D, Frenkel K, Newman MC, Sepkovic DW, Bradlow HL, Zumoff B.
    Horm Metab Res; 2003 Jun; 35(6):358-61. PubMed ID: 12920658
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study.
    Wellejus A, Olsen A, Tjonneland A, Thomsen BL, Overvad K, Loft S.
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2137-42. PubMed ID: 16172222
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effects of postmenopausal hormone replacement therapy and oral contraceptives on the endogenous estradiol metabolism.
    Mueck AO, Seeger H, Gräser T, Oettel M, Lippert TH.
    Horm Metab Res; 2001 Dec; 33(12):744-7. PubMed ID: 11753761
    [Abstract] [Full Text] [Related]

  • 7. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H, Stevenson J.
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [Abstract] [Full Text] [Related]

  • 8. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
    Ayres de Campos D, Barros H, Martinez de Oliveira J.
    Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595
    [Abstract] [Full Text] [Related]

  • 9. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858
    [Abstract] [Full Text] [Related]

  • 10. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study.
    Nozaki M, Koera K, Nagata H, Nakano H.
    J Obstet Gynaecol Res; 2004 Aug 21; 30(4):297-302. PubMed ID: 15238106
    [Abstract] [Full Text] [Related]

  • 11. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B, Pressman A, Bradley C.
    Menopause; 1998 Aug 21; 5(3):152-6. PubMed ID: 9774760
    [Abstract] [Full Text] [Related]

  • 12. Breast cancer risk with postmenopausal hormonal treatment.
    Collins JA, Blake JM, Crosignani PG.
    Hum Reprod Update; 2005 Aug 21; 11(6):545-60. PubMed ID: 16150813
    [Abstract] [Full Text] [Related]

  • 13. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR, TREAT.
    Maturitas; 2005 Sep 16; 52(1):1-10. PubMed ID: 15963666
    [Abstract] [Full Text] [Related]

  • 14. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD.
    Am J Epidemiol; 2009 Mar 15; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T, Uemura H, Umino Y, Takikawa M, Saito S, Kuwahara A, Matsuzaki T, Maegawa M, Furumoto H, Miura M, Irahara M.
    Maturitas; 2005 Jan 10; 50(1):19-29. PubMed ID: 15590210
    [Abstract] [Full Text] [Related]

  • 17. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May 10; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 18. Brassica vegetable consumption shifts estrogen metabolism in healthy postmenopausal women.
    Fowke JH, Longcope C, Hebert JR.
    Cancer Epidemiol Biomarkers Prev; 2000 Aug 10; 9(8):773-9. PubMed ID: 10952093
    [Abstract] [Full Text] [Related]

  • 19. Effects of estradiol with micronized progesterone or medroxyprogesterone acetate on risk markers for breast cancer in postmenopausal monkeys.
    Wood CE, Register TC, Lees CJ, Chen H, Kimrey S, Cline JM.
    Breast Cancer Res Treat; 2007 Jan 10; 101(2):125-34. PubMed ID: 16841178
    [Abstract] [Full Text] [Related]

  • 20. [Estrogen replacement therapy and breast cancer].
    Bakken K, Alsaker E, Eggen AE, Lund E.
    Tidsskr Nor Laegeforen; 2005 Feb 03; 125(3):282-5. PubMed ID: 15702147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.